News

Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance

Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform.

Read more

Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate

Valneva today announced the initiation of the Phase 2 Clinical Development for its leading, unique Lyme disease vaccine candidate VLA15.

Read more

HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus

The clinical trial will be conducted at approximately 35 centers worldwide and will include a total of 150 male and female patients.

Read more

Large infrastructure project PHENOPlant for phenotyping of crop plants approved

Congrats to the VBCF Plant Sciences Facility! Their FFG FuE Infrastrukturförderung application for a multi-sensor and multi-approach high-throughput…

Read more

New website for Vienna BioCenter

Vienna BioCenter launches a state-of-the-art website that lives up to the innovation and dynamism of this vibrant life science cluster.

Read more